logo lg

Diabetes Technology Update from the 2017 ADA Conference

Posted on

We’re just returning house from the most important diabetes conference of the yr, and as all the time, our ft and minds are winding down from overdrive. The large annual ADA convention never ceases to be overwhelming — held in a serious conference middle
spanning a number of blocks of metropolis area (the assembly alternates between coasts),
with a minimum of eight presentation tracks happening simultaneously over 5 days, and a sprawling exhibit corridor.

This yr, roughly 16,000 scientists, physicians, and other healthcare professionals converged on the San Diego Convention Middle between June 9-13 for the 77th Scientific Periods. There were also greater than 200 media people in attendance (together with us ‘Mine editors and different affected person bloggers), and that partially prompted one of the largest stories to return from this gi-normous annual convention addressing new research and coverings in diabetes care.

Despite its satisfaction in embracing social media (occasion nametags even touted the #2017ADA hashtag), the ADA has held on tightly to its policy banning attendees from sharing pictures publicly. But this yr, a huge Twitter storm erupted to “struggle the facility” and push for openness so that docs and sufferers unable to attend also can hear and study what’s occurring. The initiative was virtually immediately successful, with ADA conceding they need to rethink their insurance policies for subsequent yr. Ummm, yup… Those “Please delete this tweet” messages from the @AmDiabetesAssn feed have to cease and desist!

#2017ADA Photo Ban

#2017ADA Tweet

Shifting on, this is our “reporter’s notebook” of some themes we picked up on and product and know-how news from the show flooring:


Transparency, Beyond A1C, and so forth.

There was plenty of speak about transparency this yr, with regard to Access and Affordability, and in addition re: conflicts of curiosity in the relationships between Pharma and healthcare providers and non-profits. In a session on Saturday, one presenter even referred to as out docs in the viewers, asking “Who here isn’t influenced by giveaways and lunches?” Which was met with uncomfortable chuckles. There was also recognition of patients feeling out of the loop on advancements and selections that affect them (somewhat ironic given the photograph ban challenge).

Speaking of entry and affordability, have you heard about Blink Health? This newly shaped NY-based startup supplies deep reductions on prescribed drugs like by no means before, with 40% off Eli Lilly meds. Consider it or not, they’re truly offering $10M worth of FREE type 2 medications for a yr, or till the money runs out — the three most prescribed T2 medicine metformin, glipizide,
and pioglitazone. VERY COOL. Naturally, their purple and white sales space at ADA was buzzing! Notice that we simply read yesterday they’ve cut ties with Express Scripts, apparently because the PBM was not absolutely committed to offering sufferers the lowest insulin prices potential.

At ADA general, we observed many presenters and attendees taking
on the language of “Beyond A1C,” i.e. talking far more about Time in Vary as a significant measure, and the way that may and must be standardized indirectly. The subsequent FDA meeting on #BeyondA1C is planned for July 21, 2017, btw.

On the tech aspect, we also observed plenty of buzz
about new sensible insulin pens and insulin dosing apps — both bolus calculators and titration apps hitting the market (extra on that under).



A Subdued Exhibit Hall

Compared to years previous, the Exhibit Corridor was definitely quieter, with fewer video games, flashy “theaters” and swag giveaways (though One
Drop was gifting away their slick new meters!)

To be clear, the expansive exhibit hall nonetheless options hundreds of booths – from Huge Pharma “mega-booth” spreads (where recent cappuccino and frozen yogurt are on
faucet) to rows and
rows of smaller cubicles that includes non-profits and “peripheral” exhibitors displaying pores and skin creams and orthotic footwear. You possibly can nonetheless get your A1C examined on-site (in case you
don’t thoughts ready in line behind a bunch of non-D docs), and watch colourful product videos or attend an enthusiastic reside tutorial in a
Theater” area with a booming mic. This yr, Medtronic and Novo’s
Tresiba display have been utilizing Digital Actuality to supply first-hand glimpses of their offerings. 

However by comparison, it is a lot less of a party environment than it was, which from a affected person POV is definitely a great factor.


OneTouch By way of – Accepted

Huge information came within the days just earlier than the convention, as JnJ LifeScan’s OneTouch discovered that they had snagged FDA clearance for its meal bolus-only patch pump, the OneTouch Via! (previously Calibra) They discovered of the FDA 510(okay) clearance on Wednesday June 7, and in the following two days created an enormous orange oval sticker for their Exhibit Hall signage saying “Just cleared!”

This is the ultra-slim skin-colored patch pump that is Three-day wear and may hold up to 200 models. It consists of aspect buttons so you’ll be able to dose without the controller, even by means of clothing.

Meanwhile, the company’s nonetheless within the strategy of strategically evaluating its diabetes business lines — LifeScan, OneTouch, Animas, and By way of — so nothing is finalized as to launch timing. But we’re informed the hope is end of 2017 at the latest, and we’re also still awaiting word on whether or not the Animas Vibe Plus (their tubed pump integrated with the Dexcom CGM) will launch anytime quickly.


Medtronic’s Huge Win

In quite a few periods, Medtronic was the speak of
the tech world given FDA approval of the Minimed 670G
late last yr, the first hybrid closed loop that automates basal supply (you
still should punch in meal boluses) with a view to maintain you at target of ~120mg/dL. The corporate has been rolling this system out steadily over the previous few months, and
just before ADA, introduced they’d be expanding the launch to
everyone in their so-called “Priority Access Program” and to the bigger market by

In fact the 670G is an enormous milestone for Medtronic, they usually have been proudly
showcasing the gadget with an enormous
display. Additionally they had the blinded iPro2 professional CGM on show at ADA, since it is a healthcare professionals’ conference geared towards

Leading into this yr’s ADA conference, Medtronic additionally
announced that its Guardian 3 CGM sensor is now OK’d for use with the
Minimed 630G launched final yr, and not simply with the new hybrid closed loop
being launched now. The subsequent-gen sensor also comes with labeling for a barely
younger age bracket, starting at age 14 as an alternative of 16.


Dexcom Receiver & Pipeline

The company was displaying off its new touchscreen receiver, expected to launch in the August-September timeframe.

Additionally on Friday just before ADA news hit that FDA accepted the G5 Mobile app for Android, which had many enthused.

Other articles you might like;

Leave a Reply

Your email address will not be published. Required fields are marked *